Evidence map›Paper›PMID 28831255›Full record

ArticleInternational journal of nanomedicine2017

Stratum corneum lipid liposome-encapsulated panomycocin: preparation, characterization, and the determination of antimycotic efficacy against

Fatih İzgü, Günce Bayram, Kübra Tosun, Demet İzgü

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of nanomedicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Toxins · 2021
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Fatih İzgüDepartment of Molecular Biology and Genetics, Middle East Technical University, Ankara, Turkey.
Günce BayramDepartment of Biotechnology, Graduate School of Natural and Applied Sciences, Middle East Technical University, Ankara, Turkey.
Kübra TosunDepartment of Biotechnology, Graduate School of Natural and Applied Sciences, Middle East Technical University, Ankara, Turkey.
Demet İzgüBiology Department, TED Ankara College, Ankara, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, a liposomal lyophilized powder formulation of panomycocin was developed for therapeutic purposes against vulvovaginal candidiasis which affects 80% of women worldwide. Panomycocin is a potent antimycotic protein secreted by the yeast

Indexed as

Antifungal AgentsCandida albicansCandida glabrataCandidiasis, VulvovaginalDrug Delivery SystemsEpitheliumFemaleFreeze DryingGlycoside HydrolasesHumansLipidsLiposomesMycotoxinsPowdersSpectroscopy, Fourier Transform InfraredAntifungal AgentsGlycoside HydrolasesLipidsLiposomesMycotoxinspanomycocin protein, Pichia anomalaPowdersantifungal proteinCandida sppexo-β-1,3-glucanasepanomycocinstratum corneum lipid liposomevulvovaginitis

Identifiers

PMID28831255
PMCPMC5548276

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.